Prostate Cancer
Research

Volume 6 Number 1
January 2018

Home > Disciplines > Publications > Prostate Cancer Research > Volume 6, Year 2018 > Number 1, January

CONTENTS

▼

CASE REPORTS
CLASSIFICATION
DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT

CASE REPORTS

▲

CLASSIFICATION

▲

DIAGNOSIS

▲

.

Evangelista L.
Editorial Comment.
J Urol. 2016 May;195(5):1442-3. doi: 10.1016/j.juro.2015.12.107. Epub 2016 Feb 5.
Source | Full text | Similar articles
Comment on: Maurer T et al, Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer. [J Urol. 2016 May]

.

Gómez-de la Fuente FJ, Martínez-Rodríguez I, de Arcocha-Torres M, Quirce R, Jiménez-Bonilla J, Martínez-Amador N, Banzo I.
Contribution of ¹¹C-Choline PET/CT in prostate carcinoma biochemical relapse with serum PSA level below 1 ng/ml.
Rev Esp Med Nucl Imagen Mol. 2017 Nov 11. pii: S2253-654X(17)30162-2. doi: 10.1016/j.remn.2017.10.001. [Epub ahead of print] English, Spanish.
Source | Full text | Similar articles

.

Hassan O, Han M, Zhou A, Paulk A, Sun Y, Al-Harbi A, Alrajjal A, Baptista Dos Santos F, Epstein JI.
Incidence of Extra-Prostatic Extension at Radical Prostatectomy with Pure Gleason Score 3+3=6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed as "not Cancer" and for Selection Criteria for Active Surveillance.
J Urol. 2017 Nov 15. pii: S0022-5347(17)77915-3. doi: 10.1016/j.juro.2017.11.067. [Epub ahead of print]
Source | Full text | Similar articles

Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR.
Impact of ⁶⁸Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
J Nucl Med. 2017 Dec;58(12):1956-1961. doi: 10.2967/jnumed.117.192476. Epub 2017 May 18.
Source | Full text | Similar articles

.

Maurer T, Gschwend JE, Rauscher I, Souvatzoglou M, Haller B, Weirich G, Wester HJ, Heck M, Kübler H, Beer AJ, Schwaiger M, Eiber M.
Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer.
J Urol. 2016 May;195(5):1436-43. doi: 10.1016/j.juro.2015.12.025. Epub 2015 Dec 9.
Source | Full text | Similar articles

.

[No authors listed]
Reply by Authors.
J Urol. 2016 May;195(5):1443. doi: 10.1016/j.juro.2015.12.108. Epub 2016 Feb 5.
Source | Full text | Similar articles
Comment on: Evangelista L., Editorial Comment. [ J Urol. 2016 May]
In turn Comment on: Maurer T et al, Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer. [J Urol. 2016 May]

.

Oderda M, Joniau S, Palazzetti A, Falcone M, Melloni G, Van Den Bossche H, Deconinck S, Zattoni F, Karnes RJ, Gontero P.
Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy.
Eur Urol Focus. 2018 Mar;4(2):288-293. doi: 10.1016/j.euf.2015.12.004. Epub 2016 Oct 17.
Source | Full text | Similar articles

.

Rhee H, Thomas P, Shepherd B, Gustafson S, Vela I, Russell PJ, Nelson C, Chung E, Wood G, Malone G, Wood S, Heathcote P.
Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer.
J Urol. 2016 Oct;196(4):1261-7. doi: 10.1016/j.juro.2016.02.3000. Epub 2016 May 21.
Source | Full text | Similar articles

.

Taneja SS.
Re: Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
J Urol. 2017 Dec;198(6):1209-1210. doi: 10.1016/j.juro.2017.09.064. Epub 2017 Sep 15.
Source | Full text | Similar articles
Comment on: Hope TA et al., Impact of ⁶⁸Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
J Nucl Med. 2017 Dec;58(12):1956-1961. doi: 10.2967/jnumed.117.192476. Epub 2017 May 18. Source / Full text

EPIDEMIOLOGY, RISK FACTORS, PREVENTION

▲

ETIOLOGY, PATHOGENESIS, PATHOLOGY

▲

.

Chen WY, Tsai YC, Yeh HL, Suau F, Jiang KC, Shao AN, Huang J, Liu YN.
Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.
Sci Signal. 2017 Aug 15;10(492). pii: eaam6826. doi: 10.1126/scisignal.aam6826.
Source | Full text | Similar articles

FOLLOW-UP, QUALITY OF LIFE

▲

INTEGRATIVE MEDICINE

▲

OVERALL MANAGEMENT

▲

PROGNOSIS

▲

.

Bjurlin MA, Rosenkrantz AB, Sarkar S, Lepor H, Huang WC, Huang R, Venkataraman R, Taneja SS.
Prediction of Prostate Cancer Risk among Men Undergoing Combined MRI-Targeted and Systematic Biopsy Using Novel Pre-Biopsy Nomograms That Incorporate MRI Findings.
Urology. 2017 Nov 16. pii: S0090-4295(17)31185-8. doi: 10.1016/j.urology.2017.09.035. [Epub ahead of print]
Source | Full text | Similar articles

.

March B, Koufogiannis G, Louie-Johnsun M.
Management and outcomes of Gleason six prostate cancer detected on needle biopsy: A single-surgeon experience over 6 years.
Prostate Int. 2017 Dec;5(4):139-142. doi: 10.1016/j.prnil.2017.03.007. Epub 2017 Apr 7.
Source | Full text | Similar articles

.

Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P.
Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study.
Ann Oncol. 2017 Nov 17. doi: 10.1093/annonc/mdx742. [Epub ahead of print]
Source | Full text | Similar articles

.

Thalgott M, Kron M, Brath JM, Ankerst DP, Thompson IM, Gschwend JE, Herkommer K.
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy.
World J Urol. 2017 Nov 21. doi: 10.1007/s00345-017-2122-5. [Epub ahead of print]
Source | Full text | Similar articles

.

Yang DD, Mahal BA, Muralidhar V, Vastola ME, Boldbaatar N, Labe SA, Nezolosky MD, Orio PF 3rd, King MT, Martin NE, Mouw KW, Trinh QD, Nguyen PL.
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance.
Clin Genitourin Cancer. 2017 Nov 9. pii: S1558-7673(17)30329-4. doi: 10.1016/j.clgc.2017.10.013. [Epub ahead of print]
Source | Full text | Similar articles

TREATMENT

▲

.

Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A.
Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
Eur Urol. 2017 Dec 8. pii: S0302-2838(17)31005-9. doi: 10.1016/j.eururo.2017.11.020. [Epub ahead of print]
Source | Full text | Similar articles

.

Gandaglia G, Tilki D, Zaffuto E, Fossati N, Pompe RS, Dell'Oglio P, Graefen M, Montorsi F, Briganti A.
Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European Institutions.
Eur Urol Focus. 2017 Nov 16. pii: S2405-4569(17)30253-5. doi: 10.1016/j.euf.2017.10.013. [Epub ahead of print]
Source | Full text | Similar articles

.

Usón PLS Junior, Macarenco RSES, Oliveira FN, Smaletz O.
Impact of Pathology Review for Decision Therapy in Localized Prostate Cancer.
Clin Med Insights Pathol. 2017 Nov 2;10:1179555717740130. doi: 10.1177/1179555717740130. eCollection 2017.
Source | Full text | Similar articles

bottom

▲